Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation
- PMID: 8920243
- DOI: 10.1006/smim.1996.0011
Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation
Abstract
Recent studies have identified peptide-MHC molecule ligands of alpha beta T-cell receptors with properties apparently distinct from classical agonists. These complexes, which are slight structural variants of the immunizing peptide or original presenting MHC molecule, have several novel properties. They can act as partial agonists able to induce only some and not other effector activities of the T cell, as antagonists able to inhibit T-cell functions stimulated by agonist ligand, or as mixed partial agonists/antagonists. Here we discuss the existing data suggesting that a simple receptor occupancy model does not account for the properties of these TCR ligands and review emerging data on qualitative differences in signal transduction following TCR engagement by priming versus variant complexes. We propose several non-exclusive models to explain both the biochemical and biological properties of variant ligands with partial agonist or antagonist properties.
Similar articles
-
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.J Exp Med. 1993 Apr 1;177(4):1047-60. doi: 10.1084/jem.177.4.1047. J Exp Med. 1993. PMID: 8384651 Free PMC article.
-
Differential signalling by variant ligands of the T cell receptor and the kinetic model of T cell activation.Life Sci. 1999;64(9):717-31. doi: 10.1016/s0024-3205(98)00381-6. Life Sci. 1999. PMID: 10075104 Review.
-
The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.J Exp Med. 1997 Jan 20;185(2):219-29. doi: 10.1084/jem.185.2.219. J Exp Med. 1997. PMID: 9016871 Free PMC article.
-
Partial signaling by CD8+ T cells in response to antagonist ligands.J Exp Med. 1996 Jul 1;184(1):149-57. doi: 10.1084/jem.184.1.149. J Exp Med. 1996. PMID: 8691128 Free PMC article.
-
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.Immunol Today. 1993 Dec;14(12):602-9. doi: 10.1016/0167-5699(93)90200-5. Immunol Today. 1993. PMID: 8305133 Review.
Cited by
-
Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice.PLoS One. 2010 Jan 5;5(1):e8574. doi: 10.1371/journal.pone.0008574. PLoS One. 2010. PMID: 20052293 Free PMC article.
-
Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cells.Cell Mol Life Sci. 2014 Jun;71(11):2135-48. doi: 10.1007/s00018-013-1476-0. Epub 2013 Sep 26. Cell Mol Life Sci. 2014. PMID: 24067988 Free PMC article.
-
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor.J Exp Med. 1998 May 18;187(10):1699-709. doi: 10.1084/jem.187.10.1699. J Exp Med. 1998. PMID: 9584148 Free PMC article.
-
T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs.J Exp Med. 1999 Jan 18;189(2):253-64. doi: 10.1084/jem.189.2.253. J Exp Med. 1999. PMID: 9892608 Free PMC article.
-
Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain.J Exp Med. 1999 Feb 1;189(3):509-20. doi: 10.1084/jem.189.3.509. J Exp Med. 1999. PMID: 9927513 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
